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OBJECTIVES The purpose of this study was to assess the efficacy of emergency stent implantation for the
treatment of perioperative stroke after carotid endarterectomy (CEA).
BACKGROUND Carotid endarterectomy has been proven safe and effective in reducing the risk of stroke in
symptomatic and asymptomatic patients with .60% carotid artery stenosis. However,
perioperative stroke has been reported in 1.5% to 9% of CEA cases. The management of such
a complication is challenging. Recently, percutaneous transluminal carotid angioplasty with
stent deployment has emerged as a valuable and alternative strategy for the treatment of
carotid artery disease.
METHODS Between April 1998 and February 2000, 18 of the 995 patients (1.8%) who had CEA in our
institution experienced perioperative major or minor neurological complications. Of these, 13
patients underwent emergency carotid angiogram and eventual stent implantation, whereas
the remaining five had surgery re-exploration.
RESULTS Carotid angiogram was performed within 20 6 10 min and revealed vessel flow-limiting
dissection (five cases) or thrombosis (eight cases). Percutaneous transluminal carotid angio-
plasty with direct stenting (self-expandable stent) was performed in all 13 cases. Angiographic
success was 100%. Complete remission of neurological symptoms occurred in 11 of the 13
patients treated by stent implantation and in one of the five patients treated by surgical
re-exploration (p 5 0.024).
CONCLUSIONS Stent implantation seems to be a safe and effective strategy in the treatment of perioperative
stroke complicating CEA, especially when carotid dissection represents the main anatomic
problem. (J Am Coll Cardiol 2001;37:2074–9) © 2001 by the American College of
Cardiology
Carotid artery occlusive disease is responsible for 20% to
30% of stroke cases (1). Carotid endarterectomy (CEA) has
been proven safe and effective in reducing the risk of stroke
in symptomatic and asymptomatic patients with .60%
carotid artery stenosis (2,3). However, perioperative stroke
has been reported in 1.5% to 9% of CEA cases (4). Several
early reports describe poor neurological results after surgery
for acute carotid artery thrombosis (5–7). Other reports give
more satisfactory results when acute thrombosis occurs in
the immediate postoperative period and the patient is
re-explored immediately (8–10).
Recently, percutaneous transluminal carotid angioplasty
(PTA) with stent deployment has emerged as an alternative
strategy for the elective treatment of carotid artery disease
(11,12). In this study, we report the results of emergency
stent implantation for the treatment of perioperative stroke
after CEA.
METHODS
From April 1998 to February 2000, 995 patients underwent
CEA of the extracranial carotid artery in our institution.
Eighteen patients (1.8%) sustained a perioperative stroke.
Thirteen of these patients had emergency angiography with
subsequent stent implantation on the culprit carotid artery.
The remaining five patients underwent surgical re-
exploration of the carotid artery because the catheterization
laboratory was not available.
Clinical examination. “Perioperative stroke” was defined
as a stroke occurring intraoperatively (for patients treated
under local anesthesia) or in the immediate postoperative
period. Stroke was defined as an acute disturbance of focal
neurological function with symptoms that were presumably
caused by cerebral ischemia (13). A neurologist performed a
complete neurological examination, including the National
Institutes of Health (NIH) stroke scale, preoperatively, at
the time of stroke occurrence, after PTA and during
follow-up (i.e., before hospital discharge, at one and at six
months). Stroke was classified in terms of the following
definitions:
1) Category 1 minor stroke—a new neurological deficit that
changed the NIH stroke scale by 1 point and persisted
for .24 h but completely resolved or returned to
baseline within seven days.
2) Category 2 minor stroke—a new neurological deficit that
either completely resolved or returned to baseline within
30 days or that changed the NIH stroke scale by 2 or 3
points. By definition, both categories of minor stroke are
nondisabling neurological events.
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3) Major stroke—a new neurological deficit that persisted
after 30 days and changed the NIH stroke scale by $4
points.
During the surgical procedure, electroencephalogram with
simple contro-lateral hand-gripping maneuvers was used to
monitor the patient’s neurostatus. Computed tomography
of the head was performed in all patients before CEA and
after perioperative stroke occurrence.
Angiographic examination and stent implantation pro-
cedure. After the diagnosis of the complication, 13 of the
18 patients were immediately moved from the recovery
room to the cardiac catheterization laboratory, and a diag-
nostic angiographic examination was performed. A 6F
sheath was positioned in the right femoral artery, and a 6F
right Amplatz 1 diagnostic catheter (Cordis, Johnson &
Johnson Company, Miami, Florida) was advanced in the
aortic arch on a 0.035-inch guidewire, and the common
carotid artery was cannulated.
After the diagnostic angiogram, all 13 patients underwent
PTA with stent implantation. Acetylsalicylic acid (250 mg
intravenously) and unfractionated heparin (70/IU/kg) were
administered. The 6F right Amplatz 1 diagnostic catheter
was advanced into the external carotid artery over a 0.035-
in., 175-cm-long high torque guidewire (Storque supersoft,
Cordis, Johnson & Johnson Company). The guidewire was
then exchanged with a 0.035-in. Amplatz super stiff guide-
wire (Boston Scientific, Watertown, Massachusetts). This
guidewire facilitates the advancement of the 8F 80-cm kink
resistant introducer sheath (Arrow, Reading, Pennsylvania)
just before the carotid bifurcation.
The GuardWire Temporary Occlusion & Aspiration
System (PercuSurge Inc., Santa Rosa, California) (a cathe-
ter system designed to contain and retrieve particulate
material and prevent distal embolization) was used (14).
This system was advanced through the lesion in the distal
segment of the carotid artery, and the balloon was inflated
in order to occlude the vessel. The occlusive balloon was
promptly deflated if vessel occlusion was not tolerated. After
stent implantation, the Export Aspiration Catheter (Percu-
Surge Inc.) was advanced throughout the guidewire to the
occlusive balloon for the removal of debris and thrombus
accumulated in the vessel during the intervention. Stent
implantation was performed utilizing a self-expanding Easy
Wallstent (Boston Scientific). Stent deployment was done
in all lesions with the intent to cover the entire dissection or
the region of haziness. Angiographic success was defined as
achievement of a final stenosis #20%, with normal flow.
Postprocedure management. No further heparin was
given after the procedure. Sheaths were removed when the
activated clotted time was ,160 s. At discharge, oral aspirin
325 mg/day was advised to be continued indefinitely and
ticlopidine, 250 mg twice a day, for four weeks. Follow-up
was obtained by a neurological evaluation at one and six
months.
Statistical analysis. Continuous variables are presented as
mean 6 1 standard deviation. Differences between groups
were assessed by chi-square analysis for categorical variables
and Student t test for continuous variables. Probability
values ,0.05 were considered significant. Data were ana-
lyzed with SPSS 8.0 for Windows (SPSS Inc., Chicago,
Illinois).
RESULTS
Clinical and angiographic characteristics. Baseline char-
acteristics and procedural details of the 18 patients are
summarized in Table 1.
STENT GROUP (13 PATIENTS). Mean age of our population
was 65 6 5 (range 59 to 77) years. All patients had a history
of transient ischemic attack (TIA). Neurological symptoms
developed in all patients within 1 h (range 5 to 60 min) after
the surgical procedure. Angiographic examination was per-
formed within 19 6 8 min (range 8 to 35) after onset of
symptoms. The angiogram revealed a flow-limiting dissec-
tion in five (39%) patients (Fig. 1) and definite or possible
thrombus in eight cases (61%) (Fig. 2) at the site of the
previous endarterectomy.
SURGICAL GROUP (FIVE PATIENTS). Mean age was 64 6 5
(range 57 to 71) years (p 5 0.55 vs. stent group). All
patients had a history of TIA. Neurological symptoms
developed in all patients within 1 h (range 15 to 60 min)
after the surgical procedure (p 5 0.77 vs. stent group).
Surgical re-exploration was performed within 23 6 12
(range 10 to 40) min after onset of symptoms (p 5 0.17 vs.
stent group). A flow-limiting dissection occurred in three
(60%) patients and thrombus in two patients (40%) at the
site of the previous endarterectomy (p 5 0.41 vs. stent
group).
Procedural characteristics. STENT GROUP. Interval be-
tween onset of neurological symptoms and stent implanta-
tion was 46 6 11 (30 to 70) min. Angiographic success was
obtained in all patients. The self-expanding Easy Wallstent
was implanted in all cases without predilation. A post-
balloon dilation was not performed in any patient. In all
cases, vessel occlusion by the PercuSurge GuardWire system
was not tolerated. In fact, in all cases we observed a
deterioration of neurological status after balloon inflation.
Therefore, we immediately deflated the balloon and per-
formed the procedure without distal protection in all cases.
SURGICAL GROUP. The interval between onset of neurolog-
ical symptoms and surgical treatment of the complication
was 50 6 15 (range 35 to 75) min (p 5 0.77 vs. stent
Abbreviation and Acronyms
CEA 5 carotid endarterectomy
CI 5 confidence interval
NIH 5 National Institutes of Health
PTA 5 percutaneous transluminal carotid angioplasty
TIA 5 transient ischemic attack
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group). Thrombectomy was performed in all cases. Patch
implantation was necessary in the three cases where vessel
dissection occurred.
In-hospital and late outcome. In the surgical group, only
one (20%) of the five patients had complete recovery,
whereas the remaining four patients did not have any
neurological recovery (Table 1). In contrast, in the stent
group, complete remission of neurological symptoms oc-
curred in 11 (84.6%) patients. One patient died three days
after the procedure; the other patient had permanent neu-
rological deficit (p 5 0.024 vs. stent group; odds ratio 5
0.045, 95% confidence interval [CI] 5 0.003 to 0.649).
By logistic regression analysis, the only predictor of the
outcome was the treatment with stent implantation. In fact,
such a strategy improved the outcome of these patients
compared with surgical re-exploration (relative risk 5
0.045; 95% CI 5 0.003 to 0.649; p 5 0.023). In order to
better understand the potential mechanism of this result, we
separately analyzed the patients where the complication was
due to a flow-limiting dissection or to a thrombus at the site
of endarterectomy (Table 2). The outcome was better with
stent implantation only in the subgroup with a flow-limiting
dissection. In contrast, there was no difference in the
outcome in the subgroup with thrombus at the endarterec-
tomy site.
DISCUSSION
CEA and perioperative stroke. Carotid endarterectomy
has been proven safe and effective in reducing the risk of
stroke in symptomatic and asymptomatic patients with
severe carotid artery stenosis (2,3). However, perioperative
stroke has been reported in 1.5% to 9% of CEA (4).
Thrombosis after CEA is the most common cause of
perioperative stroke, accounting for up to 75% of cases
(8,15,16). Distal intimal flap, furthermore, represents an-
other important cause of such a complication (17,18). The
results of our study confirm the prevalent role of thrombosis
(56% of cases) and underline the importance of a flow-
limiting dissection (44% of cases) as the cause of the
perioperative stroke. The eversion endarterectomy tech-
nique is faster and more effective in reducing restenosis than
conventional technique. However, one of the major draw-
backs associated with eversion endarterectomy is a distal
intimal flap that may develop after flow restoration (19).
Identification of vessel dissection is very accurate by
angiographic examination. However, it has been reported
that angiography requires at least 1 h to perform. This
additional time required to reach a diagnosis is justified if
the diagnostic procedure (carotid angiography) has a ther-
apeutic counterpart.
Treatment of perioperative stroke. The main finding of
this study was that stent implantation seems to be more
effective than surgical re-exploration in the treatment of
perioperative stroke, especially when the problem is due to
vessel dissection. This result confirms data of previous
studies by our group (17) as well as other (18) investigators,
suggesting that stent implantation is an expeditious tech-
nique to treat carotid dissection occurring after eversion
CEA.
The relevant role of distal dissection after CEA may also
explain why surgical re-exploration has a variable, and
sometimes poor, result (5–10). Immediate re-exploration
includes thrombectomy or patch implantation (20). The
poor results that have been experienced with re-exploration
for thrombosis have partially been explained by Kwann et al.
(21) who pointed out the critical role of time for recovering
from neurological insult. More satisfactory results have been
achieved when acute thrombosis occurs in the immediate
postoperative period and the patient is immediately re-
explored (8–10). Immediate thrombectomy of the throm-
Table 1. Baseline Characteristics and Procedural Details











1 63 M RICA Eversion CEA Stent Dissection 85 0 Minor Recovery
2 65 F LICA Eversion CEA Stent Thr 90 0 Major No recovery
3 63 M RICA Eversion CEA Stent Dissection 90 10 Minor Recovery
4 64 M LICA Eversion CEA Stent Thr 75 20 Minor Recovery
5 63 M RICA Eversion CEA Stent Dissection 80 0 Minor Recovery
6 62 M LICA Eversion CEA Stent Thr 75 20 Minor Recovery
7 65 M RICA Standard CEA Stent Thr 85 0 Minor Recovery
8 60 F RICA Eversion CEA Stent Dissection 80 20 Minor Recovery
9 77 M LICA Eversion CEA Stent Thr 90 0 Major Death
10 66 M RICA Eversion CEA Stent Thr 90 15 Minor Recovery
11 68 M RICA Eversion CEA Stent Thr 80 0 Minor Recovery
12 59 M LICA Eversion CEA Stent Thr 90 10 Minor Recovery
13 66 F LICA Eversion CEA Stent Dissection 95 10 Minor Recovery
14 71 M LICA Eversion CEA Surgery Thr Minor Recovery
15 65 M LICA Eversion CEA Surgery Thr Major No recovery
16 68 F RICA Eversion CEA Surgery Thr 1 Dissection Minor No recovery
17 57 F RICA Eversion CEA Surgery Thr 1 Dissection Minor No recovery
18 61 M RICA Standard CEA Surgery Thr 1 Dissection Major No recovery
CEA 5 carotid endarterectomy; DS 5 diameter stenosis; LICA 5 left internal carotid artery; Pt 5 patient; RICA 5 right internal carotid artery; Thr 5 thrombus.
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bosed carotid artery leads to restoration of flow and reversal
of ischemic changes before permanent neurological damage
develops. Complete recovery usually occurs when delay is
,1 h. However, even with immediate re-exploration, the
result may be unsuccessful when dealing with carotid
dissection. In particular, it may be especially troublesome
when dissection arises above the Blaisdell’s line (an imagi-
nary line between the mastoid process and the angle of the
mandible). The necessity for greater exposure often means
that more time is needed for dissection or other maneuvers
at a point of considerable inconvenience during the opera-
tion (18).
The appropriate means to treat distal intracranial dissec-
tion is still controversial. Intraoperative stent placement,
accomplished through the use of endovascular technique or
placement of a self-expanding stent under direct vision,
Figure 1. (A) Left internal carotid artery after eversion carotid endarter-
ectomy. The arrow indicates a flow-limiting dissection in the proximal
segment of the internal carotid artery. (B) Final angiographic result after
placement of an auto-expandable Easy Wallstent.
Figure 2. (A) Left internal carotid artery after eversion carotid endarter-
ectomy. The angiogram shows a large thrombus in the proximal segment
of the internal carotid artery. (B) Final angiographic result after placement
of an auto-expandable Easy Wallstent.
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represents an attractive expeditious method to treat dissec-
tion after CEA (17,18).
Study limitations. This retrospective, nonrandomized
study represents a single-center experience with a relatively
small sample size. We did not have any predetermined
criteria for the selection of patients to be treated by carotid
stenting or surgical re-exploration. In fact, all surgical
re-exploration included in the study was performed because
it was impossible to perform angioplasty. Cerebral protec-
tion devices are considered essential to prevent distal em-
bolization during elective carotid angioplasty. We tried to
use the PercuSurge GuideWire (the only protection device
available at the time of the study), but it was not tolerated
in all patients. This unexpected event may be due to: 1) lack
of a “preconditioning-like” effect (22), and 2) cerebral
autoregulatory dysfunction (23). The filters that trap debris
during intervention, without occluding the artery, can now
overcome the limitations of the balloon occlusion type
device.
Recently, glycoprotein IIb/IIIa antagonists have been
used in different thrombogenic settings, like acute myocar-
dial infarction, with promising preliminary results (24,25).
Although in eight of our 13 patients there was the angio-
graphic evidence of thrombus, we did not use these drugs
because of the risk of intracerebral hemorrhage (26,27).
Conclusions and clinical implications. This preliminary
experience with primary stenting for the treatment of
post-CEA stroke is encouraging and needs to be tested
further in a larger sample size. This encouraging clinical
result may be also explained by the fact that the interval
between onset of neurological symptoms and stent implan-
tation was 46 6 11 (range 30 to 70) min. For this reason, we
think that a meticulous neurological monitoring and a
prompt availability of a catheterization laboratory emer-
gency team are crucial for the efficacy of such a strategy for
the treatment of perioperative stroke.
Acknowledgments
The authors are indebted to Raimondo Bellanca, RN, and
Piero Vitale, RN, for their technical support.
Reprint requests and correspondence: Dr. Antonio Colombo,
Interventional Cardiology Unit, San Raffaele Hospital, Via Olget-
tina, 60, 20132 Milan, Italy. E-mail: segreteria.emodinamica@hsr.it.
REFERENCES
1. De Bakey MH. Carotid endarterectomy revisited. J Endovasc Surg
1996;3:4.
2. North American Symptomatic Carotid Endarterectomy Trial Collab-
orators. Beneficial effect of carotid endarterectomy in symptomatic
patients with high-grade carotid stenosis. N Engl J Med 1991;325:
445–53.
3. Executive Committee for the Asymptomatic Carotid Atherosclerosis
Study. Endarterectomy for asymptomatic carotid artery stenosis.
JAMA 1995;273:1421–8.
4. Zarins CK. Carotid endarterectomy: the gold standard. J Endovasc
Surg 1996;3:10–5.
5. Thompson JE, Austin DJ, Patman RD. Endarterectomy of the totally
occluded carotid artery for stroke. Arch Surg 1967;95:791–801.
6. De Weese JA. Management of acute stroke. Surg Clin North Am
1982;62:467–72.
7. Wylie EJ, Hein MF, Adams JE. Intracranial hemorrhage following
surgical revascularization for treatment of acute strokes. J Neurosurg
1964;21:212–5.
8. Towne JB, Bernhard VM. The relationship of postoperative hyper-
tension to complications following carotid endarterectomy. Surgery
1980;88:575–80.
9. Treiman RL, Cossman DV, Cohen JL, et al. Management of
postoperative stroke after carotid endarterectomy. Am J Surg 1981;
142:236–8.
10. Simma W, Hesse H, Gilhofer G, et al. Management of immediate
occlusion after carotid reconstruction. J Cardiovasc Surg 1987;28:
176–9.
11. Wholey MH, Wholey M, Bergeron P, et al. Current global status of
carotid artery stent placement. Cathet Cardiovasc Diagn 1998;44:1–6.
12. Shawl F, Kadro W, Domanski MJ, et al. Safety and efficacy of elective
carotid artery stenting in high-risk patients. J Am Coll Cardiol
2000;35:1721–8.
13. WHO Task Force on Stroke and Other Cerebrovascular Disorders.
Report of the WHO Task Force on Stroke and Others Cerebrovas-
cular Disorders: recommendations on stroke prevention, diagnosis and
therapy. Stroke 1989;20:1407–31.
14. Carlino M, De Gregorio J, Di Mario C, et al. Prevention of distal
embolization during saphenous vein graft lesion angioplasty: experi-
ence with a new temporary occlusion and aspiration system. Circula-
tion 1999;99:3221–3.
15. Koslow AR, Ricotta JJ, Ouriel K, et al. Re-exploration for thrombosis
in carotid endarterectomy. Circulation 1989;80 Suppl III:73–8.
16. Aburahma AF, Robinson PA, Short YS. Management options for
post-carotid endarterectomy stroke. J Cardiovasc Surg 1996;37:331–6.
17. Melissano G, Chiesa R, Sheiban I, et al. Intraoperative stenting of the
internal carotid artery after unsuccessful eversion endarterectomy. J
Vasc Surg 1999;30:355–6.
18. Ross CB, Ranval TJ. Intraoperative use of stents for the management
of unacceptable distal internal carotid artery end points during carotid
endarterectomy: short-term and mid-term results. J Vasc Surg 2000;
32:420–8.
19. Rosenthal D, Zeichner WD, Lamis PA, Stanton PE. Neurological
deficit after carotid endarterectomy: pathogenesis and management.
Surgery 1983:94:776–80.
20. Paty PS, Darling RC, III, Cordero JA, Jr, et al. Carotid artery bypass
in acute postendarterctomy thrombosis. Am J Surg 1996;172:181–3.
21. Kwann JH, Connolly JE, Sharefkin JB. Successful management of
early stroke after carotid endarterectomy. Ann Surg 1979;190:676–8.
22. Plaschke K, Weigand MA, Michel A, et al. Permanent cerebral
hypoperfusion: “preconditioning-like” effects on rat energy metabolism
towards acute systemic hypotension. Brain Res 2000;858:363–70.
Table 2. Clinical Characteristics and Outcome in the Stent and
Surgery Groups According to the Presence of a Thrombus or a







Thrombus Group 8 Patients 2 Patients
Age 67 6 5 68 6 4 0.67
Gender (male) 7 (87.5%) 2 (100%) 0.60
Time to treatment (min) 51 6 10 42 6 10 0.84
Outcome 0.49
Recovery 6 (75%) 1 (50%)
No recovery 2 (25%) 1 (50%)
Dissection Group 5 Patients 3 Patients
Age 61 6 2 62 6 6 0.10
Gender (male) 4 (80%) 1 (33%) 0.19
Time to treatment (min) 42 6 8 55 6 18 0.35
Outcome 0.005
Recovery 5 (100%) 0
No recovery 0 3 (100%)
2078 Anzuini et al. JACC Vol. 37, No. 8, 2001
Perioperative Carotid Stenting June 15, 2001:2074–9
23. MacGregor DG, Carswell HVO, Graham DI, et al. Impaired cerebral
autoregulation 24 h after induction of transient unilateral focal
ischemia in the rat. Eur J Neurosci 2000;12:58–66.
24. Comerot Eze AR. Intraoperative high-dose regional urokinase infu-
sion for cerebrovascular occlusion after carotid endarterectomy. J Vasc
Surg 1996;24:1008–16.
25. Del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in acute
stroke: possibilities and hazards. Stroke 1986;17:595–607.
26. Babikian VL, Kase CS, Pessin MS, et al. Intracerebral hemorrhage in
stroke patients anticoagulated with heparin. Stroke 1989;20:1500–3.
27. Donnan GA, Davis SM, Chambers BR, et al. Trials of streptokinase
in severe acute ischemic stroke. Lancet 1995;345:578–9.
2079JACC Vol. 37, No. 8, 2001 Anzuini et al.
June 15, 2001:2074–9 Perioperative Carotid Stenting
